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Background: Scutellaria baicalensis (S. baicalensis) is one of the traditional Chinese medicinal herbs that have been
shown to possess many health benefits. In the present study, we evaluated the in vitro antiviral activity of aqueous
extract of the roots of S. baicalensis against all the four dengue virus (DENV) serotypes.
Methods: Aqueous extract of S. baicalensis was prepared by microwave energy steam evaporation method
(MEGHE™), and the anti-dengue virus replication activity was evaluated using the foci forming unit reduction assay
(FFURA) in Vero cells. Quantitative real-time polymerase chain reaction (qRT-PCR) assay was used to determine the
actual dengue virus RNA copy number. The presence of baicalein, a flavonoid known to inhibit dengue virus
replication was determined by mass spectrometry.
Results: The IC50 values for the S. baicalensis extract on Vero cells following DENV adsorption ranged from 86.59 to
95.19 μg/mL for the different DENV serotypes. The IC50 values decreased to 56.02 to 77.41 μg/mL when cells were
treated with the extract at the time of virus adsorption for the different DENV serotypes. The extract showed potent
direct virucidal activity against extracellular infectious virus particles with IC50 that ranged from 74.33 to 95.83 μg/
mL for all DENV serotypes. Weak prophylactic effects with IC50 values that ranged from 269.9 to 369.8 μg/mL were
noticed when the cells were pre-treated 2 hours prior to virus inoculation. The concentration of baicalein in the S.
baicalensis extract was ~1% (1.03 μg/gm dried extract).
Conclusions: Our study demonstrates the in vitro anti-dengue virus replication property of S. baicalensis against all
the four DENV serotypes investigated. The extract reduced DENV infectivity and replication in Vero cells. The extract
was rich in baicalein, and could be considered for potential development of anti-DENV therapeutics.
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Many traditionally used herbs contain phytochemicals
that could be beneficial for health. These plant-derived
compounds and extracts have been used in many forms
for the treatment of various ailments and as dietary
supplements [1-3]. Traditionally used herbal prepara-
tions commonly used by different communities across
the world, have been the immediate source of knowledge
for further discovery of potentially beneficial phytochem-
icals. It is a widely believed that naturally-derived phy-
tochemicals would have lesser side-effects as they are* Correspondence: sazaly@um.edu.my
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reproduction in any medium, provided the oroften derived from edible herbs [4-6]. The traditional
Chinese medicinal practices advocate the use of herbs,
many of which have been extensively characterized and
studied [7,8]. Among these herbs include those that have
been described to possess anti-infective properties
[9-11]. Traditionally, most of these herbal-based medica-
tions are dispensed in aqueous forms, and be adminis-
tered orally [12]. Given the availability of huge number
of traditionally used medicinal plants, it is likely that at
least a few of these would exhibit antiviral activities at
concentrations suitable for direct consumption [13].
S. baicalensis is one of the most widely used medicinal
plants, and is officially listed in the Chinese Pharmacopoeia
[14]. Extracts of its roots have been widely used in the
treatment of inflammation, cancer, infectious diseases,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of this plant contain a plethora of bioactives, for instance
different types of flavonoids such as baicalein and wogonin
[15]. Recently, we showed that several flavonoids including
quercetin, fisetin [16,17] and baicalein [18] possessed
significant antiviral activities against dengue viruses
(DENV).
Dengue is a serious viral disease in the tropical and
subtropical regions of the world, and accounts for
~500,000 hospital admissions annually and consumes
massive hospital resources [19]. Dengue is currently one
of the most rapidly spreading mosquito-borne diseases
that is estimated to pose health threat to ~2.5 billion
people living in endemic regions [19,20]. Dengue virus
(DENV) is an enveloped virus belonging to the
Flaviviridae family with four distinct serotypes (DENV-
1, DENV-2, DENV-3 and DENV-4) [19]. Currently, there
is no specific anti-dengue medication available and treat-
ment is only supportive [21]. In addition, there is no
approved dengue vaccine available heretofore. Hence,
there is an urgent and immediate necessity to explore an
effective antiviral strategy against dengue. Since, single
molecule antiviral drug development is a cumbersome,
time-consuming and highly expensive endeavour, an
efficient traditional herbal preparation could be an
immediate alternative. Herein, we investigated the
potentials of aqueous extract of S. baicalensis against the
four DENV serotypes in regards to inhibition of different
stages of replication in vitro.
Methods
Plant extract
S. baicalensis dried ground roots extract (AHPE-XA-09)
used in the current investigation was provided by
Herbitec Sdn Bhd (Malaysia), prepared using its own
propriety method. Briefly, microwave energy generated
steam was used to prepare the aqueous extract. The
extract prepared in deionized water as a stock solution
with concentration 60 mg/ml, was stored at −20°C.
Before use in the experiments, the stock solution was
clarified and sterilized using a syringe filter with 0.2
micron pore size (Millipore, MA, USA). Eagle’s mini-
mum essential medium (EMEM) (Gibco, NY, USA) was
used as a diluent to prepare the different concentrations
of the extract.
Standardization of extract and mass spectrometry
Identification and quantitation of the active compound,
baicalein, in AHPE-XA-09 was performed by liquid
chromatography-mass spectrometry-mass spectrometry
(LC/MS/MS). Briefly, the concentration of pure baicalein
ranging from 0.5 μg/mL to 20 μg/mL (Indofine Chemical
Company Inc., New Jersey, USA) was dissolved in metha-
nol (BDH Laboratory Supplies, England) and injected(10 μl) into the Applied Biosystems 3200 LC/MS/MS
System (California, USA). Compound separation was
achieved on a Gemini C6-Phenyl 110A column (150
mm×2.00 mm, particle diameter of 5 μm) (Phenomenex,
USA) with a mobile phase composed of 0.1% formic acid
(BDH Laboratory Supplies, England): acetonitrile (BDH
Laboratory Supplies, England) at a flow rate of 0.50 mL/
min. The transition ions and retention times were used as
a detection point for baicalein peak. The transition ions
were monitored in the multiple reaction monitoring
modes (MRM). The area under the curve based on the
different intensity height in the chromatogram of the
different concentrations of baicalein was used to plot a
standard linear regression curve. The AHPE-XA-09 (100
μg/mL lyophilized powder) was dissolved in methanol,
filtrated through 0.45 μm PVDF filter (Whatman, USA)
and was subsequently injected into the LC/MS/MS
System. Inverse prediction method for the best fit linear
regression curve generated from the pure baicalein was
used for quantitation of the concentration of baicalein in
AHPE-XA-09.
Cells and virus
C6/36 mosquito cell line was used for the propagation
of all DENV isolates used in the investigation [16]. Vero
(African green monkey kidney) cell line was used for the
evaluation of antiviral activity as previously described
[18]. The cell lines were maintained and propagated in
EMEM (Gibco, NY, USA) containing 10% fetal bovine
serum (FBS, Gibco, NY, USA). The C6/36 and Vero cells
were incubated at 28°C and 37°C respectively, in the
presence of 5% CO2. At the time of virus inoculation
and antiviral assays, the concentration of FBS was
reduced to 2%. We used four different clinical DENV
isolates representing the four serotypes of DENV
(DENV-1, DENV-2, DENV-3 and DENV-4) in current
investigation which identified by our group using full
genome sequencing method. All the four clinical iso-
lates propagated and maintained as previously de-
scribed [17]. After titration of the virus isolates, the
stocks were stored at −70°C until further use in the
experiments.
In vitro cytotoxicity assay
The cytotoxic potential of AHPE-XA-09 extract against
Vero cells was determined using the MTT assay as
described previously [19]. Briefly, the confluent Vero
cells in 96-well microplates were treated with different
concentrations of AHPE-XA-09 in triplicates. The
treated cells were incubated with the extract for four
days, which was similar to the time period for the anti-
viral assay at 37°C followed by the addition of 15 μl of
MTT solution to each well. The microplate was further
incubated at 37°C for four hours and subsequently a
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Figure 1 Cytotoxicity effects of S. baicalensis extract, AHPE-XA-
09, on Vero cells. Data are presented as percentage of cell viability
from triplicate assay.
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ity (OD) of all the wells including non-treated cells was
read using a plate reader (TECAN, Mannendorf,
Switzerland) at 570 nm. The cytotoxicity of AHPE-XA
-09 was calculated using Graph Pad Prism 5 (Graph Pad
Software Inc., San Diego, CA).
Antiviral activity assays
The effect of AHPE-XA-09 on intracellular replication of
DENV was examined in Vero cells plated on 24-well cell
culture microplate. After attaining 80% confluency, virus
inoculum consisting of 200 FFU of each DENV serotype
was added to each well. Viruses were allowed to adsorb
to the cells for 1 hour at 37°C. Unadsorbed viruses were
removed by rinsing the cells with sterile PBS twice.
Different concentrations of AHPE-XA-09 were mixed
with 1.5% carboxymethylcellulose (CMC) containing a
cell-growth medium supplemented with 2% FBS and the
plates were incubated at 37°C for four days. DENV foci
were visualized as described previously [19]. The num-
ber of foci formed was expressed as foci-forming unit
(FFU). The antiviral effects of AHPE-XA-09 was
measured by calculating the percentage of foci reduction
(% RF) against the controls maintained in parallel using
the following formula [16]; RF (%) = (C-T) × 100/C,
where, C is the mean of the number of foci from tripli-
cates without AHPE-XA-09 added and T is the mean of
the number of foci from triplicates of each treatment
with AHPE-XA-09 extract.
Time of addition studies
Prophylactic activity assay
The effects of prophylactic activity of AHPE-XA-09 prior
to DENV infection were examined by treating a conflu-
ent monolayer of Vero cell line with different concentra-
tions of AHPE-XA-09 for 5 h before DENV inoculation.
The treatment medium was aspirated after 5 h, and the
cells were washed twice with sterile PBS, and then
infected with 200 FFU of each DENV serotypes. The
microplate was kept at 37°C for 1 h to allow virus
adsorption. Following virus adsorption, the infectedTable 1 Primer sequences used for q-RT-PCR of DENV
Virus serotype Primer sequence
DENV-1 Forward: 5′ CAA TAT GCT GAA ACG CGC GAG AAA 3′
Reverse: 5′ GCT CCA TTC TTC TTG AAT GA 3′
DENV-2 Forward: 5′ CAA TAT GCT GAA ACG CGA GAG AAA 3′
Reverse: 5′ AAG ACA TTG ATG GCT TTT GA 3′
DENV-3 Forward: 5′ CAA TAT GCT GAA ACG CGT GAG AAA 3′
Reverse: 5′ GAA GGT TCC CCA TCT AGC CA 3′
DENV-4 Forward: 5′ GAA GTG AAA ACA TGT CTG TGG CCC A 3′
Reverse: 5′ TTC ACA GCA CAA TTA CCG CCA G 3′monolayer was rinsed twice with sterile PBS and sup-
plemented with 2% FBS containing EMEM with 1.5%
CMC and the corresponding concentrations of the
extract. Later, the plates were incubated at 37°C for 4
days in the presence of 5% CO2. Viral foci were stained
and counted as described above.Anti-adsorption activity assay
The effect of AHPE-XA-09 against DENVs adsorption
and attachment to the Vero cells was determined by
simultaneously adding the different concentrations of
AHPE-XA-09 extract and 200 FFU DENV to Vero cells.
The treated cells were washed with PBS after 1 h incuba-
tion at 37°C and supplemented with 2% FBS containing
EMEM with 1.5% CMC. The plates were incubated at 37°C
for 4 days with 5% CO2. Viral foci were stained and
counted as described above.Table 2 IC50 values of the S. baicalensis extract, AHPE-XA-
09, against the different stages of replication of DENV
serotypes
Antiviral
activity
Prophylactic
activity IC50
(μg/mL)
Anti-
adsorption
activity IC50
(μg/mL)
After
adsorption
activity IC50
(μg/mL)
Direct
virucidal
activity IC50
(μg/mL)Virusserotype
DENV-1 269.9 69.14 86.59 91.93
DENV-2 369.8 56.02 93.66 95.83
DENV-3 330.3 77.41 89.39 93.68
DENV-4 345.8 73.59 95.19 74.33
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The potential direct virucidal effects of AHPE-XA-09 on
DENV were evaluated by treating the viral suspension
with 200 FFU of DENV with increasing concentrations
of AHPE-XA-09 for 2 h at 37°C. The confluent Vero
cells in 24-well plate were infected with the AHPE-XA-
09-treated viral suspensions. After 1 h of adsorption at
37°C, the cells were washed twice with PBS and overlaid
with 1.5% CMC-containing cell culture medium. The
microplate was incubated for 4 days in a humidified
37°C incubator in the presence of 5% CO2. The viral foci
were visualized as described above.
Quantitative real-time polymerase chain reaction (qRT-PCR)
AHPE-XA-09 effects on DENV RNA production was
determined using qRT-PCR as previously described
[22,23]. Different primer sets for detection of the 4
different DENV serotypes were used based on previous
designed primers [22,23] with some minor modifications
(Table 1). This experiment was undertaken to confirm
the foci forming assay results.
Statistical analysis
The half maximal cytotoxicity concentration (CC50) and
half maximal inhibitory concentration (IC50) were used0 200 400 600 800
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Figure 2 Prophylactic effects of S.baicalensis extract against DENVs. F
prophylactic activity of the plant extract on DENVs in vitro replication (A) and
for all four DENV serotypes (B). Data from triplicate assays were plotted usingas the main parameters in this investigation. Selectivity
index value (SI) was determined as the ratio of CC50/
IC50 of the plant extract. GraphPad PRISM for
Windows, version 5 (GraphPad Software Inc., San Diego,
CA, 2005) was used for all statistical analyses.
Results and Discussion
Cytotoxicity of S .Baicalensis on Vero cells
The toxicity of AHPE-XA-09 extract was measured
against Vero cells using the MTT assay. We found that
72 ± 2.9% of the cells were viable after 4 days of treat-
ment with AHPE-XA-09 at concentration 375 μg/mL.
Also, we found that in presence of 187.5 μg/mL the
viability of treated cells was 81.4 ± 1.3. The half maximal
cytotoxic concentration (CC50) value for AHPE-XA-09
was at 912.6 μg/mL (Figure 1). This suggests that
AHPE-XA-09 at concentrations <375 μg/mL is in
general non-cytotoxic and could be well-tolerated by
Vero cells.
Antiviral assays and mechanisms of action of AHPE-XA-09
against DENV
The foci-forming unit reduction assay (FFURA) together
with qRT-PCR, were used to evaluate the in vitro anti-
dengue activity of the aqueous extract of S.baicalensis.0.0
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Graph Pad Prism Version 5 (Graph Pad Software Inc., San Diego, CA).
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tic effect ii) activity against virus adsorption to cells, iii)
ability to inhibit replication after virus adsorption to the
cells and iv) direct virucidal effect. The S. baicalensis
extract, AHPE-XA-09, exhibited a dose-dependent in-
hibition effect against all the four DENV serotypes in
Vero cells with IC50 values as presented in Table 2. It
was demonstrated that the plant extract showed antiviral
activity against the different DENV serotypes used at all
stages of in vitro replication, although the most sig-
nificant effects were observed when the extract was
evaluated during the time of virus adsorption (Table 2).
Protective prophylactic effect
AHPE-XA-09 exhibited prophylactic effect against
DENV replication in Vero cells, with the IC50 values
ranging from 269.9 to 369.8 μg/mL for all the four
DENV serotypes tested (Table 2, Figure 2A). The SI
values for all the four DENV serotypes ranged between
2.47 and 3.38 (DENV-1, SI= 3.4; DENV-2, SI= 2.5;
DENV-3, SI= 2.8; DENV-4, SI= 2.6). When the cells
when pre-treated with the extract at a concentration of
750 μg/mL, the RNA levels in all the DENV serotypes
decreased by >70% as compared to untreated cells0 200 400 600 800
0
20
40
60
80
100
DENV-1
DENV-2
DENV-3
DENV-4
Concentration (µg/mL)
(A)
Fo
ci
 
re
du
ct
io
n
 (%
)
0
20
40
60
80
100
R
N
A 
Le
v
el
 
R
ed
uc
tio
n
 (%
)
Figure 3 Anti-adsorption activity of S.baicalensis extract against DENV
evaluate the effect of plant extract on DENVs adsorption and attachment t
were quantified by qRT-PCR for all 4 DENV serotypes (B). Data from triplica
Software Inc., San Diego, CA).(Figure 2B). These observations could be due to the
uptake of the plant extract by the cells during pre-
treatment and their potential activity against the intra-
cellular replication of DENVs and/or could be related to
the masking of the viral receptors on the cell surface
due to competitive binding of the bioactives present in
the plant extract. Nonetheless, the anti-DENV activity of
AHPE-XA-09 via prophylactic treatment in Vero cells
was relatively less significant as compared to the other
treatments (Table 2). Therefore, it could be further
improved probably by optimizing the time of exposure
and dose for effective pre-treatment.
Activity against virus adsorption to cells
The antiviral activity of AHPE-XA-09 against DENV was
found to be the most effective as it acts by inhibiting the
virus adsorption to cells. The IC50 values ranged from
56.02 to 77.41 μg/mL for all the four DENV serotypes
studied (Table 2, Figure 3A) with SI values ranged from
11.7 to 16.6 (DENV-1, SI= 13.2; DENV-2, SI= 16.3;
DENV-3, SI= 11.8 and DENV-4 SI= 12.4). Interestingly,
we also found that the DENV viral RNA reduced
by ~68% to 82% at 187 μg/mL of AHPE-XA-09 added
during the viral adsorption period (Figure 3B). This0.0
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http://www.biomedcentral.com/1472-6882/13/91could be associated with the direct virucidal activity
of the plant extract (Table 2), which possibly could
have decreased the number of infectious DENVs
particles during the adsorption time and/or binding
to the cognate cellular receptors for DENVs. However,
interfering with the virus attachment to the cells via
binding to cell surface receptors and/or virus ligand
could be another explanation for the anti-adsorp-
tion activity of the extract, which warrants further
investigations.
Ability to inhibit intracellular viral replication
Next, we set out to investigate the intracellular anti-
dengue credentials of the plant extract DENV-infected
Vero cells. Following the addition of AHPE-Xa-09 subse-
quent to DENV infection of Vero cells, we noticed an
inhibition of DENV replication with IC50 values ranging
from 86.59 to 95.19 μg/mL for the different DENV sero-
types examined (Table 2, Figure 4A). The extract in this
experiment showed SI values ranging from 9.5 to 10.5
(DENV-1, SI= 10.5; DENV-2, SI= 9.7; DENV-3, SI= 10.2
and DENV-4 SI= 9.6). The findings were convincingly
supported by the results from qRT-PCR analysis, which
showed a decrease of viral RNA yield by >50% at 93 μg/mL
of the extract used, and a reduction of viral RNA by at0 200 400 600 800
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Figure 4 Effects of S.baicalensis extract against DENVs intracellular re
determine the antiviral activity of the plant extract on DENVs after adsorpti
levels were quantified by qRT-PCR for all 4 DENV serotypes (B). Data from t
Pad Software Inc., San Diego, CA).least 90% at 750 μg/mL of the extract used as compared
to the non-treated cells (Figure 4B). Similar findings have
been reported by others where the extract from the roots
of S. baicalensis have shown antiviral activity against
respiratory syncytial virus (RSV) with a SI value of 10.7
[12]. It has also been established that a flavone from the
roots of S .baicalensis possessed significant antiviral acti-
vity against influenza viruses when used after virus
adsorption to the susceptible cell line [24].Direct virucidal effects
It was demonstrated that AHPE-Xa-09 exhibited a
potent extracellular anti-DENVs effect against all the
four DENV serotypes. Inhibition of DENV replication in
Vero cells was significant when AHPE-XA-09 was pre-
incubated with the viruses, with IC50 values ranging
from 74.33 to 95.83 μg/mL for the different DENV sero-
types (Table 2, Figure 5A). The SI values of the extract
in this part of the investigation ranged between 9.5 and
12.3 (DENV-1, SI= 9.9; DENV-2, SI= 9.5; DENV-3,
SI= 9.7; DENV-4, SI= 12.3). The extract at 187 μg/mL
decreased the RNA production of DENVs at the range
of 77–83% (Figure 5B) as compared to the non-treated
virus inoculum.0.0
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Figure 5 Direct virucidal activity of S. baicalensis extract against DENVs. Foci forming unit reduction assay (FFURA) was performed to
evaluate the direct virucidal effects of the plant extract on DENVs (A) and the respective DENVs RNA production levels were quantified by
qRT-PCR for all 4 DENV serotypes (B). Data from triplicate assays were plotted using Graph Pad Prism Version 5 (Graph Pad Software Inc., San
Diego, CA).
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AHPE-XA-09
LC/MS/MS of the pure baicalein (0.5–20 μg/mL) was
initially performed to establish a standard curve using
area under the curve based on the different intensity
height in the chromatogram of the different baicalein
concentrations. A linear plot with R2 value of >0.996
was obtained. A transition ion with the MRM of mass-
to-change-ratio (m/z) 270.9/122.9 atomic mass units
(amu) and retention time of 3.14 minutes was monitored
for pure baicalein. This enabled us to identify and
confirm the presence of baicalein in AHPE-XA-09.
Using the standard curve plotted from pure baicalein
(Figure 6A), the amount of baicalein in 100 μg/mL of
AHPE-XA-09, which showed intensity of 1.80 × 104
counts per second (cps), was at 1.03 μg/mL (Figures 6A
and 6B). The amount of baicalein present in AHPE-XA-
09 was consistent with those reported from extraction of
S. baicalensis roots using many other methods [25,26].
Recent lines of evidence suggest that certain com-
pounds from the S. baicalensis extract, such as baicalein
or chrysin, showed antiviral activity against hepatitis A
virus (HAV), which is an RNA virus. However, the
mechanism(s) underlying the mode of action of thesecompounds remain elusive [27]. Indeed, antiviral activity
of 5,7,4'-trihydroxy-8-methoxyflavone a flavonoid from
the roots of S. baicalensis was shown against influenza
viruses [24,28].
Recently, we have shown the novel antiviral activity of
pure commercial baicalein against DENV-2 (NGC
strain) [18]. Therefore, our current investigations point
to the potential use of cold water extract of the roots of
S. baicalensis, AHPE-XA-09 as one of the main source
for baicalein, although some other bioactives present in
the extract could also possess anti-DENV activities. The
anti-DENV activities of S. baicalensis extract were no-
ticeable at all stages of in vitro infection; when the cells
were treated after virus adsorption, during the virus
adsorption or even prior to virus infection. The tested
extract exerted significant direct virucidal effects on
extracellular free DENVs particles, which is a notable
ability for anti-dengue candidate to neutralize free
viruses at viremic stages. The mechanism of how the
extract precisely inhibits DENVs replication remains
ambiguous. However, our findings suggest that one
possible mechanism whereby the S. baicalensis extract
acts against DENV replication could be attributed to its
ability to bind and/or to inactivate certain important
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Figure 6 Standard curve of the pure baicalein and LC/MS/MS chromatogram of AHPE-XA-09. Pure baicalein standard linear regression
curve was plotted from the area under the curve based on the different intensity height determined from the chromatogram of the different
concentrations of pure baicalein. The intensity of baicalein in the AHPE-XA-09 was extrapolated from the plot (indicated by a dot line) (A). LC/MS/
MS chromatogram shows the intensity and retention time of baicalein in the AHPE-XA-09 (B).
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Such inhibitory mechanism has previously been reported
with some flavonoids such as pinostrobin against DENV
NS2B/NS3 protease [29]. Moreover, it has been demon-
strated that baicalein, as a main flavonoid found in the
tested extract, is able to bind to HIV-1 integrase [30].
On the other hand, the activity of flavonoids such as
wogonin and baicalein has been demonstrated against
cellular DNA and RNA besides their ability to inactivatethe cellular RNA polymerases [31-33]. Therefore, it may
be another potential mechanism for the tested plant
extract and its constituents to inhibit the DENV replica-
tion via interference with DENV RNA polymerase and/
or viral RNA, which is open for future investigations.
Conclusions
In conclusion, the cold aqueous extract of the roots of
S. baicalensis, one of the traditional Chinese medicinal
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http://www.biomedcentral.com/1472-6882/13/91herbs used to treat infectious diseases, exhibited a novel
anti-dengue activity against all four serotypes of DENV
in vitro. Our investigations have shown that this extract
specifically targeted different stages of DENV infection
and replication in vitro. Our study also demonstrated
the potent direct virucidal activity of S. baicalensis
extract, which serves as an important criteria for anti-
dengue drug development as it could neutralize extracel-
lular DENVs circulating in viremic patients. Our findings
also highlight the potentials of S. baicalensis aqueous
extract for use as anti-dengue agent, and the presence of
baicalein, a known flavonoid with anti-dengue virus
replication properties perhaps is one of the possible
naturally active antiviral constituents.
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